Epidemiological Study to Describe Non Small Cell Lung Cancer (NSCLC) Clinical Management Patterns in Central Eastern Europe and Russia (Lung-EPICLIN)

CompletedOBSERVATIONAL
Enrollment

840

Participants

Timeline

Start Date

February 28, 2010

Primary Completion Date

March 31, 2011

Study Completion Date

March 31, 2012

Conditions
Non Small Cell Lung Cancer
Trial Locations (31)

Unknown

Research Site, Barnaul

Research Site, Birobidzhan

Research Site, Khabarovsk

Research Site, Khanty-Mansyisk

Research Site, Krasnodar

Research Site, Vladivostok

Research Site, Kazan'

Research Site, Yakutsk

Research Site, Arkhangelsk

Research Site, Belgorod

Research Site, Blagoveshchensk

Research Site, Chita

Research Site, Engel's

Research Site, Irkutsk

Research Site, Kemerovo

Research Site, Khimki

Research Site, Moscow

Research Site, Nizhny Novgorod

Research Site, Novosibirsk

Research Site, Obninsk

Research Site, Omsk

Research Site, Oryol

Research Site, Perm

Research Site, Pyatigorsk

Research Site, Saint Petersburg

Research Site, Samara

Research Site, Tomsk

Research Site, Tula

Research Site, Volgograd

Research Site, Yuzno-Sakhalinsk

Research Site, Zhukovsky

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY